Applications for Neuroprotection: The Next Therapeutic Category in Retina Medicine

 In News

Retina Today – October 2014
By Pravin U. Dugel, M.D.

Leading retinal specialist and industry opinion leader Pravin U. Dugel, MD, discusses ONL Therapeutics’ core technology and its significant potential to treat retinal disease.

Leave a Comment

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search